Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1590]
News [2163]
Articles [129]
Editorials [10]
Conferences [117]
elearning [20]
BGICC 2019
BGICC 2019 ( )
28 Jan 2019
APT for HER2 breast cancer patients with small tumours
Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon
APT for HER2 breast cancer patients with small tumours ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )
28 Jan 2019
History and current status of breast cancer treatment in Sweden
Prof Kerstin Sandelin - Karolinska Institutet, Solna, Sweden
History and current status of breast cancer treatment in Sweden ( Prof Kerstin Sandelin - Karolinska Institutet, Solna, Sweden )
28 Jan 2019
Where does neoadjuvant chemotherapy in advanced ovarian cancer fit in clinical...
Prof Sean Kehoe - University of Birmingham, Birmingham, UK
Where does neoadjuvant chemotherapy in advanced ovarian cancer fit in clinical practice? ( Prof Sean Kehoe - University of Birmingham, Birmingham, UK )
28 Jan 2019
Shortening the time taken to get breast cancer patients diagnosed in Latin...
Dra Cynthia Villareal-Garzia - Monterrey Institute of Technology, Monterrey...
Shortening the time taken to get breast cancer patients diagnosed in Latin America ( Dra Cynthia Villareal-Garzia - Monterrey Institute of Technology, Monterrey, Mexico )
22 Jan 2019
The rehabilitation of breast cancer survivors
Dr Mary Reid - Roswell Park Cancer Institute, USA
The rehabilitation of breast cancer survivors ( Dr Mary Reid - Roswell Park Cancer Institute, USA )
4 Jan 2019
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from...
Dr Dejan Juric - Massachusetts General Hospital, Boston, USA
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial ( Dr Dejan Juric - Massachusetts General Hospital, Boston, USA )
14 Dec 2018
Polygenic risk scores for breast cancer: ready or not?
Prof Gareth Evans - University of Manchester, Manchester, UK
Polygenic risk scores for breast cancer: ready or not? ( Prof Gareth Evans - University of Manchester, Manchester, UK )
14 Dec 2018
Modulation of anti-tumour immunity using CDK4/6 inhibitors
Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA
Modulation of anti-tumour immunity using CDK4/6 inhibitors ( Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2018
Brain metastases developed from HER2 positive and triple negative breast cancer
Dr Patricia Steeg - National Cancer Institute, Bethesda, USA
Brain metastases developed from HER2 positive and triple negative breast cancer ( Dr Patricia Steeg - National Cancer Institute, Bethesda, USA )
14 Dec 2018
Association of pathologic complete response following neoadjuvant chemotherapy...
Dr Laura Spring - Harvard Medical School, Boston, USA
Association of pathologic complete response following neoadjuvant chemotherapy with longterm survival in breast cancer ( Dr Laura Spring - Harvard Medical School, Boston, USA )
14 Dec 2018
Results from adding adjuvant capecitabine to treatment for breast cancer...
Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain
Results from adding adjuvant capecitabine to treatment for breast cancer patients ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )
13 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation